Skip to main content

Table 1 Encouraging results of MSCs application in animal kidney transplantation models

From: Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation

Year

Animal

MSCs source

Timing of infusion

Outcomes

References

2010

Mice

BM-MSCs

Day 1

↑IDO, ↑kyneurenine, ↓DCs and T cells, ↑Tregs, ↓AR, ↑graft renal function and survival

Ge et al. [26]

2013

Rats

BM-MSCs

Day 0

↓T and B cells, ↓AR, ↑graft renal function

Koch et al. [27]

2017

Mice

BM-MSCs-MVs

Day 1

↑miR-146a, ↓DCs, ↑graft renal function and survival

Wu et al. [28]

2017

Rats

BM-MSCs

Two injections (day − 7, 0 or day − 4, 0)

↓T, B, and NK cells, ↑Tregs, ↓graft inflammation, ↑graft renal function and survival

Merino et al. [29]

2017

Rats

BM-MSCs

Three injections (day 0, 3, 7)

↓AR, ↓pathological score, ↓TGF-β1

Yu et al. [30]

2007

Rats

BM-MSCs

Four injections (day − 7, 0, 7, 14)

↓AR, ↑graft renal function and survival

Zhang et al. [31]

2012

Mice

BM-MSCs

Day − 7 or day − 1 or day − 7, − 1

↑Tregs, ↓AR, ↑graft renal function and survival

Casiraghi et al. [32]

2010

Rats

BM-MSCs

Day 0

↓AR, ↓pathological score, ↑graft renal function

Zonta et al. [33]

2012

Rats

BM-MSCs

Day 77

↑IDO, ↓IF/TA, ↓graft inflammation, ↑graft renal function

Franquesa et al. [34]

2014

Porcine

AF-MSCs

Day 6

↑Graft renal function, ↓fibrosis

Baulier et al. [35]

2011

Rats

BM-MSCs

Three injections (day − 7, 0, 1)

↓Graft inflammation,

Hara et al. [36]

  1. MSCs mesenchymal stem cells, BM-MSCs bone marrow MSCs, BM-MSCs-MVs MVs originated from bone marrow MSCs, AF-MSCs amniotic fluid-derived MSCs, IDO indoleamine 2, 3-dioxgenase, DCs dendritic cells, Tregs regulatory T cells, AR acute rejection, NK cells natural killer cells, IF/TA interstitial fibrosis/tubular atrophy